Enveric Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $5.58 million, with shareholders equity totaling $8.08 million.
The company employs approximately 3 people and operates in the Health sector, within the Pharmaceutical Products industry.
Over the past 12 months, Enveric Biosciences Inc. reported $- in revenue, generating net income of $-8.73 million.
Key financial metrics include a P/E ratio of -0.64, a price-to-book (P/B) ratio of 0.69, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ENVB.